Regulatory roles of c-jun in H5N1 influenza virus replication and host inflammation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 12, 2014, Pages 2479-2488

  Xie, Jingjing ^a   Zhang, Shouping ^a   Hu, Yanxin ^a   Li, Dirui ^a   Cui, Jingmin ^a   Xue, Jia ^a   Zhang, Guozhong ^a   Khachigian, Levon M ^b,f   Wong, Jonathan ^c   Sun, Lunquan ^d   Wang, Ming ^a,e  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

^e CENTRAL SOUTH UNIVERSITY   (China)

^f Key Laboratory of Veterinary Bioproduction and Veterinary Medicine of the Ministry of Agriculture Zhongmu Institute of China Animal Husbandry Industry Co Ltd   (China)

Author keywords

C jun; DNAzyme; H5N1; Inflammation

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA INTERFERON; DNA; DNAZYME; INTERLEUKIN 10; INTERLEUKIN 6; PROTEIN C JUN; PROTEIN SERINE THREONINE KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; CYTOKINE;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENETIC REGULATION; GENETIC TRANSFECTION; HOST; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H5N1; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; SURVIVAL RATE; VIRUS LOAD; VIRUS PNEUMONIA; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; DOG; DRUG EFFECTS; GENE SILENCING; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INFLAMMATION; MDCK CELL LINE; METABOLISM; ORTHOMYXOVIRUS INFECTION; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TUMOR CELL LINE; VIROLOGY; WESTERN BLOTTING;

ANIMALS; ANTHRACENES; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; DOGS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INFLUENZA A VIRUS, H5N1 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; VIRUS REPLICATION;

EID: 84910078012     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.04.017     Document Type: Article

References (43)

1. Stephenson I., Zambon M. The epidemiology of influenza. Occup. Med. (Lond.) 2002, 52:241-247.
2. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol. Rev. 1992, 56:152-179.
3. WHO Human animal interface avian influenza in humans http://www.who.int/influenza/human_animal_interface/avian_influenza/h5n1_research/en/index.html.
4. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., Hoang D.M., Chau N.V., Khanh T.H., Dong V.C., Qui P.T., Cam B.V., Ha do Q., Guan Y., Peiris J.S., Chinh N.T., Hien T.T., Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006, 12:1203-1207.
5. Ludwig S., Planz O., Pleschka S., Wolff T. Influenza-virus-induced signaling cascades: targets for antiviral therapy?. Trends Mol. Med. 2003, 9:46-52.
6. Us D. Cytokine storm in avian influenza. Mikrobiyol Bull. 2008, 42:365-380.
7. Palese P. Influenza: old and new threats. Nat. Med. 2004, 10:S82-S87.
8. de Jong M.D., Tran T.T., Truong H.K., Vo M.H., Smith G.J., Nguyen V.C., Bach V.C., Phan T.Q., Do Q.H., Guan Y., Peiris J.S., Tran T.H., Farrar J. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 2005, 353:2667-2672.
9. Cheung C.L., Rayner J.M., Smith G.J., Wang P., Naipospos T.S., Zhang J., Yuen K.Y., Webster R.G., Peiris J.S., Guan Y., Chen H. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J. Infect. Dis. 2006, 193:1626-1629.
10. Ludwig S., Planz O. Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy. Biol. Chem. 2008, 389:1307-1312.
11. Kumar N., Xin Z.T., Liang Y., Ly H. NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J. Virol. 2008, 82:9880-9889.
12. Nimmerjahn F., Dudziak D., Dirmeier U., Hobom G., Riedel A., Schlee M., Staudt L.M., Rosenwald A., Behrends U., Bornkamm G.W., Mautner J. Active NF-kappaB signalling is a prerequisite for influenza virus infection. J. Gen. Virol. 2004, 85:2347-2356.
13. Nacken W., Ehrhardt C., Ludwig S. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses. Biol. Chem. 2012, 393:525-534.
14. Ludwig S., Ehrhardt C., Neumeier E.R., Kracht M., Rapp U.R., Pleschka S. Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J. Biol. Chem. 2001, 276:10990-10998.
15. Ludwig S., Pleschka S., Planz O., Wolff T. Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell. Microbiol. 2006, 8:375-386.
16. Sumbayev V.V., Yasinska I.M. Role of MAP kinase-dependent apoptotic pathway in innate immune responses and viral infection. Scand. J. Immunol. 2006, 63:391-400.
17. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1991, 1072:129-157.
18. Bohmann D., Bos T.J., Admon A., Nishimura T., Vogt P.K., Tjian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 1987, 238:1386-1392.
19. Meng Q., Xia Y. c-Jun, at the crossroad of the signaling network. Protein Cell 2011, 2:889-898.
20. Devary Y., Gottlieb R.A., Lau L.F., Karin M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell Biol. 1991, 11:2804-2811.
21. Leppa S., Bohmann D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 1999, 18:6158-6162.
22. ludwig S. Influenza viruses and MAP kinase cascades - novel targets for an antiviral intervention?. Signal Transduct. 2007, 81-88.
23. Maurer B., Serfling E., ter Meulen V., Rethwilm A. Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat. J. Virol. 1991, 65:6353-6357.
24. Schubert S., Gul D.C., Grunert H.P., Zeichhardt H., Erdmann V.A., Kurreck J. RNA cleaving '10-23' DNAzymes with enhanced stability and activity. Nucleic Acids Res. 2003, 31:5982-5992.
25. Fahmy R.G., Waldman A., Zhang G., Mitchell A., Tedla N., Cai H., Geczy C.R., Chesterman C.N., Perry M., Khachigian L.M. Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun. Nat. Biotechnol. 2006, 24:856-863.
26. Zhang G., Dass C.R., Sumithran E., Di Girolamo N., Sun L.Q., Khachigian L.M. Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. J. Natl. Cancer Inst. 2004, 96:683-696.
27. Gaur P., Munjhal A., Lal S.K. Influenza virus and cell signaling pathways. Med. Sci. Monit. 2011, 17:RA148-RA154.
28. Chan M.C., Cheung C.Y., Chui W.H., Tsao S.W., Nicholls J.M., Chan Y.O., Chan R.W., Long H.T., Poon L.L., Guan Y., Peiris J.S. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 2005, 6:135.
29. Han D., Hu Y., Li L., Tian H., Chen Z., Wang L., Ma H., Yang H., Teng K. Highly pathogenic porcine reproductive and respiratory syndrome virus infection results in acute lung injury of the infected pigs. Vet. Microbiol. 2014, 169:135-146.
30. Romero-Lopez C., Barroso-delJesus A., Puerta-Fernandez E., Berzal-Herranz A. Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method. Biol. Chem. 2005, 386:183-190.
31. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 2002, 4:E131-E136.
32. Colin L., Vandenhoudt N., de Walque S., Van Driessche B., Bergamaschi A., Martinelli V., Cherrier T., Vanhulle C., Guiguen A., David A., Burny A., Herbein G., Pancino G., Rohr O., Van Lint C. The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication. PLoS One 2011, 6:e19084.
33. Nayak D.P., Hui E.K., Barman S. Assembly and budding of influenza virus. Virus Res. 2004, 106:147-165.
34. Cilloniz C., Pantin-Jackwood M.J., Ni C., Goodman A.G., Peng X., Proll S.C., Carter V.S., Rosenzweig E.R., Szretter K.J., Katz J.M., Korth M.J., Swayne D.E., Tumpey T.M., Katze M.G. Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J. Virol. 2010, 84:7613-7624.
35. Bone R.C. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 1996, 125:680-687.
36. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13681-13686.
37. Van der Velden J., Janssen-Heininger Y.M., Mandalapu S., Scheller E.V., Kolls J.K., Alcorn J.F. Differential requirement for c-Jun N-terminal kinase 1 in lung inflammation and host defense. PLoS One 2012, 7:e34638.
38. Sabapathy K., Kallunki T., David J.P., Graef I., Karin M., Wagner E.F. c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J. Exp. Med. 2001, 193:317-328.
39. Conze D., Krahl T., Kennedy N., Weiss L., Lumsden J., Hess P., Flavell R.A., Le Gros G., Davis R.J., Rincon M. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation. J. Exp. Med. 2002, 195:811-823.
40. Wong J.P., Christopher M.E., Salazar A.M., Sun L.Q., Viswanathan S., Wang M., Saravolac E.G., Cairns M.J. Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza. Front. Biosci. (Schol. Ed.) 2010, 2:791-800.
41. Zhang L., Yang L., Li J.J., Sun L. Potential use of nucleic acid-based agents in the sensitization of nasopharyngeal carcinoma to radiotherapy. Cancer Lett. 2010, 323:1-10.
42. Bhindi R., Fahmy R.G., Lowe H.C., Chesterman C.N., Dass C.R., Cairns M.J., Saravolac E.G., Sun L.Q., Khachigian L.M. Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies. Am. J. Pathol. 2007, 171:1079-1088.
43. Cho E.A., Moloney F.J., Cai H., Au-Yeung A., China C., Scolyer R.A., Yosufi B., Raftery M.J., Deng J.Z., Morton S.W., Hammond P.T., Arkenau H.T., Damian D.L., Francis D.J., Chesterman C.N., Barnetson R.S., Halliday G.M., Khachigian L.M. Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). Lancet 2013, 381:1835-1843.